3386 — Cosmo Bio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapContrarian

Annual income statement for Cosmo Bio Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,590	8,092	9,231	9,553	9,340
Cost of Revenue
Gross Profit	2,880	3,152	3,659	3,441	3,250
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,266	7,340	8,183	8,766	8,794
Operating Profit	324	752	1,048	787	546
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	388	1,008	1,099	790	653
Provision for Income Taxes
Net Income After Taxes	246	701	769	552	462
Minority Interest
Net Income Before Extraordinary Items
Net Income	238	674	738	517	443
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	237	674	737	517	442
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	48.6	114	127	92.5	72.6
Dividends per Share